Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 373.03 | 356.14 | 358.14 | 374.27 | 1,136.98 |
| Operating profit | 88.27 | 73.81 | 76.74 | 76.79 | 231.54 |
| Interest | 4.10 | 3.82 | 4.03 | 5.80 | 14.69 |
| Gross profit | 84.37 | 69.99 | 77.57 | 70.99 | 218.13 |
| EPS (Rs) | 5.32 | 4.61 | 5.26 | 4.41 | 14.54 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 0.20 | - | 4.86 | - | 1.28 |
| Stock adjustment | -5.32 | -6.11 | -19.29 | -8.70 | -82.53 |
| Raw material | 191.11 | 196.88 | 193.64 | 210.12 | 689.33 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 34.29 | 29.84 | 31.53 | 30.94 | 91.22 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 64.68 | 61.72 | 75.52 | 65.12 | 207.42 |
| Provisions made | - | - | - | - | - |
| Depreciation | 16.94 | 16.32 | 15.44 | 14.25 | 41.52 |
| Taxation | 19.25 | 11.86 | 14.50 | 16.75 | 44.88 |
| Net profit / loss | 48.19 | 41.81 | 47.63 | 39.99 | 131.73 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.31 | 45.31 | 45.31 | 45.31 | 45.31 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.66 | 20.72 | 21.43 | 20.52 | 20.36 |
| GPM (%) | 22.61 | - | 21.37 | - | 19.16 |
| NPM (%) | 12.91 | - | 13.12 | - | 11.57 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis